Related Articles
Mitogen-activated protein kinase phosphatase 1 is involved in tamoxifen resistance in MCF7 cells
EZH2 inhibition sensitizes tamoxifen‑resistant breast cancer cells through cell cycle regulation
Long non‑coding RNA UCA1 confers tamoxifen resistance in breast cancer endocrinotherapy through regulation of the EZH2/p21 axis and the PI3K/AKT signaling pathway10.3892/ijo.2024.5611
Cyclooxygenase-2 utilizes Jun N-terminal kinases to induce invasion, but not tamoxifen resistance, in MCF-7 breast cancer cells
Potential of endogenous estrogen receptor β to influence the selective ER modulator ERβ complex